The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example Alzheimer's disease.
本发明涉及抑制Lp-P
LA2活性的新化合物,其制备方法,含有这些化合物的组合物以及它们在治疗与Lp-P
LA2活性相关的疾病中的应用,例如阿尔茨海默病。